Equilab International, PT was established in November 2002. Through incessant research and innovation this company dedicated to provides services in Bioavailability/Bioequivalence (BA/BE) study and comprehensive Clinical Trial. To fulfill these need, Equilab develops two business area, BA/BE Unit and Clinical Research Unit. Our BA/BE Unit is the first ISO 17025:2005 accredited BA/BE laboratory in Indonesia and offers a lot numbers of bioanalytical capabilities with validated and accredited status. Our Clinical Research Unit provides wide range of clinical trial activities.

Located in Jakarta, Indonesia, our laboratory has an integrated clinical and analytical site. Our system and facilities are managed to meet the regulatory requirements. Supported by good quality system, our greatest asset is our dedicated personnels with professional work ethics, responsiveness, expertise, and GCP certification. Their commitment to excellence will deliver time and cost effective project with integrity and validity of clinical trial data, reliable result, and comply with GCP and GLP international standard to be acceptable by Drug Regulatory Authority in the destination registration countries.

With our commitment to bring client’s trust into client’s satisfaction, Equilab will be your reliable partner in conducting BA/BE study and clinical trial in a long term relationship in order to accelerate your drug development process.